LoginSignup
UCB SA logo

UCB SA

Stock
Stock
ISIN: BE0003739530
Ticker: UCB
BE0003739530
UCB

Price

Price

Historical dividends and forecast

All dividend data

UCB SA has so far distributed $1.451 in 2024. The next dividend will be paid on 30.04.2025

$1.272

CHART BY

Frequently asked questions

What is UCB SA's market capitalization?

The market capitalization of UCB SA is $35.25B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is UCB SA's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for UCB SA is 141.56. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for UCB SA?

UCB SA's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $1.28. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for UCB SA's stock?

Currently, 21 analysts cover UCB SA's stock, with a consensus target price of $147.48. Analyst ratings provide insights into the stock's expected performance.

What is UCB SA's revenue over the trailing twelve months?

Over the trailing twelve months, UCB SA reported a revenue of $5.68B.

What is the EBITDA for UCB SA?

UCB SA's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $1.25B. EBITDA measures the company's overall financial performance.

What is the free cash flow of UCB SA?

UCB SA has a free cash flow of $322.59M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of UCB SA's stock?

The 5-year beta for UCB SA is 0.62. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does UCB SA have, and what sector and industry does it belong to?

UCB SA employs approximately 9,083 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of UCB SA's shares?

The free float of UCB SA is 119.23M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $35.25B

5Y beta

 0.62

EPS (TTM)

 $1.28

Free Float

 119.23M

P/E ratio (TTM)

 141.56

Revenue (TTM)

 $5.68B

EBITDA (TTM)

 $1.25B

Free Cashflow (TTM)

 $322.59M

Pricing

1D span
$182.31$186.76
52W span
$73.03$200.19

Analyst Ratings

The price target is $147.48 and the stock is covered by 21 analysts.

Buy

14

Hold

7

Sell

0

Information

Ucb SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. In the area of central nervous system disorders, the Company is focused on epilepsy, diabetic neuropathic pain, multiple sclerosis, fibromyalgia, restless legs syndrome and Parkinson’s disease, and the area of immunology includes, bone loss disorders, Crohn’s disease, rheumatoid arthritis and respiratory disease. In addition to its core fields of business, Ucb SA delivers molecule solutions to specialists for use in the treatment of severe diseases. Its product portfolio includes drugs, such as Neupro, Vimpat, Cimzia, among others. Ucb SA also operates in primary care to support specialist products that are administered by primary care physicians.

9,083

Biotechnology & Drugs

Health Care

Identifier

ISIN

BE0003739530

Primary Ticker

UCB

Knockouts

Join the conversation
Sign upLogin